Federal contract award
75F40121C00136
EXTENSIVE DATABASE CONSTRUCTION AND STATISTICAL ANALYSIS TOOLS WILL CONVERT REAL-WORLD DATA INTO INFORMATION ABOUT DRUG QUALITY. PYTHON WILL BE USED BOTH TO CONSTRUCT DATABASES AND ANALYZE DATA. SAS WILL ALSO BE USED TO PROVIDE STATISTICAL CORRELA
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $755.6K |
| Current contract value | $755.6K |
| Potential contract value / ceiling | $755.6K |
| Start date | Sep 17, 2021 |
| Current end date | Sep 29, 2023 |
| Potential end date | Sep 29, 2023 |
| Latest award activity | Aug 17, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 17, 2026 | P00003 | $-38.4K | UPDATE COR TO JENEEN HUFF-ROBERSONE FROM ENIAFE RHODA |
| Aug 1, 2023 | P00002 | $0 | UPDATE COR TO JENEEN HUFF-ROBERSONE FROM ENIAFE RHODA |
| Dec 19, 2022 | P00001 | $0 | EXTENSIVE DATABASE CONSTRUCTION AND STATISTICAL ANALYSIS TOOLS WILL CONVERT REAL-WORLD DATA INTO INFORMATION ABOUT DRUG QUALITY. PYTHON WILL BE USED BOTH TO CONSTRUCT DATABASES AND ANALYZE DATA. SAS WILL ALSO BE USED TO PROVIDE STATISTICAL CORRELA |
| Sep 17, 2021 | 0 | $794.0K | EXTENSIVE DATABASE CONSTRUCTION AND STATISTICAL ANALYSIS TOOLS WILL CONVERT REAL-WORLD DATA INTO INFORMATION ABOUT DRUG QUALITY. PYTHON WILL BE USED BOTH TO CONSTRUCT DATABASES AND ANALYZE DATA. SAS WILL ALSO BE USED TO PROVIDE STATISTICAL CORRELA |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Kimberly DeLong | Contact | kimberly.delong@fda.hhs.gov 2404028639 | Source | May 26, 2021 |
| Robert Maydwell | Contact | Robert.Maydwell@fda.hhs.gov 301-348-1814 | Source | May 26, 2021 |
| Kimberly DeLong | Contact | kimberly.delong@fda.hhs.gov 2404028639 | Source | May 26, 2021 |
| Anthony S. Wimbush | Contact | anthony.wimbush@fda.hhs.gov 2404027628 | Source | May 26, 2021 |
| Kimberly DeLong | Contact | kimberly.delong@fda.hhs.gov 2404028639 | Source | Jan 28, 2021 |
| Anthony S. Wimbush | Contact | anthony.wimbush@fda.hhs.gov 2404027628 | Source | Jan 28, 2021 |
| Benjamin Golway | Contact | Benjamin.Golway@fda.hhs.gov 3018374464 | Source | Nov 20, 2020 |
| Anthony S. Wimbush | Contact | anthony.wimbush@fda.hhs.gov 2404027628 | Source | Nov 20, 2020 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.